Press Releases Keyword Search Year None202520242023202220212020201920182017 June 12, 2025 FibroGen Announces 1-for-25 Reverse Stock Split June 9, 2025 FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors May 12, 2025 FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update May 5, 2025 FibroGen to Report First Quarter 2025 Financial Results April 2, 2025 FibroGen to Participate in the 24th Annual Needham Virtual Healthcare Conference March 28, 2025 FibroGen Announces Publication of Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology March 17, 2025 FibroGen Reports Fourth Quarter and Full Year 2024 Financial Results March 3, 2025 FibroGen to Report Fourth Quarter and Full Year 2024 Financial Results February 20, 2025 FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million
